Practical points in urinary proteomics

Journal of Proteome Research

Volumn 6, Issue 10, 2007, Pages 3881-3890

  Thongboonkerd, Visith ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Biomarker discovery; Guidelines; Kidney; Proteome; Sample preparation; Urinary proteomics; Urine; Variabilities

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; PROTEINASE INHIBITOR;

ARTICLE; BIOINFORMATICS; GENETIC VARIABILITY; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN STRUCTURE; PROTEIN URINE LEVEL; PROTEOMICS; STATISTICAL ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

BIOLOGICAL MARKERS; HUMANS; PROTEINURIA; PROTEOME; PROTEOMICS; SPECIMEN HANDLING;

EID: 35649000519     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070328s     Document Type: Article

References (48)

1. Thongboonkerd, V.; Malasit, P. Renal and urinary proteomics: Current applications and challenges. Proteomics 2005, 5, 1033-1042.
2. Thongboonkerd, V. Recent progress in urinary proteomics. Proteomics Clin. Appl. 2007, 1, 780-791.
3. Mischak, H.; Apweiler, R.; Banks, R. E.; Conaway, M.; Coon, J.; Dominicsak, A.; Ehrich, J. H. H.; Fliser, D.; Girolami, M.; Goodsaid, F.; Hermjakob, H.; Hochstrasser, D.; Jankowski, J.; Julian, B. A.; Kolch, W.; Massy, Z. A.; Neusuess, C.; Novak, J.; Peter, K.; Rossing, K.; Schanstra, J.; Semmes, J.; Theodorescue, D.; Thongboonkerd, V.; Weissinger, E. M.; Van Eyk, J. E.; Yamamoto, T. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
4. Pisitkun, T.; Johnstone, R.; Knepper, M. A. Discovery of urinary biomarkers. Mol. Cell Proteomics 2006, 5, 1760-1771.
5. D'Amico, G.; Bazzi, C. Pathophysiology of proteinuria. Kidney Int. 2003, 63, 809-825.
6. Thongboonkerd, V. Proteomic analysis of renal diseases: Unraveling the pathophysiology and biomarker discovery. Expert Rev. Proteomics 2005, 2, 349-366.
7. Schaub, S.; Wilkins, J.; Weiler, T.; Sangster, K.; Rush, D.; Nickerson, P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 2004, 65, 323-332.
8. Nguyen, M. T.; Ross, G. F.; Dent, C. L.; Devarajan, P. Early prediction of acute renal injury using urinary proteomics. Am. J. Nephrol. 2005, 25, 318-326.
9. Woroniecki, R. P.; Orlova, T. N.; Mendelev, N.; Shatat, I. F.; Hailpern, S. M.; Kaskel, F. J.; Goligorsky, M. S.; O'Riordan, E. Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am. J. Nephrol. 2006, 26, 258-267.
10. Fliser, D.; Wittke, S.; Mischak, H. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes. Electrophoresis 2005, 26, 2708-2716.
11. Kolch, W.; Neususs, C.; Pelzing, M.; Mischak, H. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 2005, 24, 959-977.
12. Weissinger, E. M.; Hertenstein, B.; Mischak, H.; Ganser, A. Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis. Expert Rev. Proteomics 2005, 2, 639-647.
13. Liu, B. C.; Zhang, L.; Lv, L. L.; Wang, Y. L.; Liu, D. G.; Zhang, X. L. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am. J. Nephrol. 2006, 26, 483-490.
14. Thongboonkerd, V.; Songtawee, N.; Sritippayawan, S. Urinary proteome profiling using microfluidic technology on a chip. J. Proteome Res. 2007, 6, 2011-2018.
15. Fliser, D.; Novak, J.; Thongboonkerd, V.; Argiles, A.; Jankowski, V.; Girolami, M. A.; Jankowski, J.; Mischak, H. Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 2007, 18, 1057-1071.
16. Mischak, H.; Julian, B. A.; Novak, J. High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin. Appl. 2007, 1, 792-804.
17. Angenendt, P. Progress in protein and antibody microarray technology. Drug Discovery Today 2005, 10, 503-511.
18. Thongboonkerd, V.; McLeish, K. R.; Arthur, J. M.; Klein, J. B. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002, 62, 1461-1469.
19. Thongboonkerd, V.; Chutipongtanate, S.; Kanlaya, R. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J. Proteome Res. 2006, 5, 183-191.
20. Pieper, R.; Gatlin, C. L.; McGrath, A. M.; Makusky, A. J.; Mondal, M.; Seonarain, M.; Field, E.; Schatz, C. R.; Estock, M. A.; Ahmed, N.; Anderson, N. G.; Steiner, S. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004, 4, 1159-1174.
21. Oh, J.; Pyo, J. H.; Jo, E. H.; Hwang, S. I.; Kang, S. C.; Jung, J. H.; Park, E. K.; Kim, S. Y.; Choi, J. Y.; Lim, J. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 2004, 4, 3485-3497.
22. Wittke, S.; Fliser, D.; Haubitz, M.; Battel, S.; Krebs, R.; Hausadel, F.; Hillmann, M.; Golovko, I.; Koester, P.; Haller, H.; Kaiser, T.; Mischak, H.; Weissinger, E. M. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J. Chromatogr. A 2003, 1013, 173-181.
23. Haubitz, M.; Wittke, S.; Weissinger, E. M.; Walden, M.; Rupprecht, H. D.; Floege, J.; Haller, H.; Mischak, H. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005, 67, 2313-2320.
24. Meier, M.; Kaiser, T.; Herrmann, A.; Knueppel, S.; Hillmann, M.; Koester, P.; Danne, T.; Haller, H.; Fliser, D.; Mischak, H. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J. Diabetes Complications 2005, 19, 223-232.
25. Hampel, D. J.; Sansome, C.; Sha, M.; Brodsky, S.; Lawson, W. E.; Goligorsky, M. S. Toward proteomics in uroscopy: urinary protein profiles after radiocontrast medium administration. J. Am. Soc. Nephrol. 2001, 12, 1026-1035.
26. Schaub, S.; Rush, D.; Wilkins, J.; Gibson, I. W.; Weiler, T.; Sangster, K.; Nicolle, L.; Karpinski, M.; Jeffery, J.; Nickerson, P. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 219-227.
27. O'Riordan, E.; Orlova, T. N.; Podust, V. N.; Chander, P. N.; Yanagi, S.; Nakazato, M.; Hu, R.; Butt, K.; Delaney, V.; Goligorsky, M. S. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am. J. Transplant. 2007, 7, 930-940.
28. Davis, M. T.; Spahr, C. S.; McGinley, M. D.; Robinson, J. H.; Bures, E. J.; Beierle, J.; Mort, J.; Yu, W.; Luethy, R.; Patterson, S. D. Towards defining the urinary proteome using liquid chromatography- tandem mass spectrometry. II. Limitations of complex mixture analyses. Proteomics 2001, 1, 108-117.
29. Spahr, C. S.; Davis, M. T.; McGinley, M. D.; Robinson, J. H.; Bures, E. J.; Beierle, J.; Mort, J.; Courchesne, P. L.; Chen, K.; Wahl, R. C.; Yu, W.; Luethy, R.; Patterson, S. D. Towards defining the urinary proteome using liquid chromatography- tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics 2001, 1, 93-107.
30. Cutillas, P. R.; Norden, A. G.; Cramer, R.; Burlingame, A. L.; Unwin, R. J. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clin. Sci. (London) 2003, 104, 483-490.
31. Cutillas, P. R.; Chalkley, R. J.; Hansen, K. C.; Cramer, R.; Norden, A. G.; Waterfield, M. D.; Burlingame, A. L.; Unwin, R. J. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2004, 287, F353-F364.
32. Cutillas, P. R.; Norden, A. G.; Cramer, R.; Burlingame, A. L.; Unwin, R. J. Urinary proteomics of renal Fanconi syndrome. Contrib. Nephrol. 2004, 141, 155-169.
33. Sun, W.; Li, F.; Wu, S.; Wang, X.; Zheng, D.; Wang, J.; Gao, Y. Human urine proteome analysis by three separation approaches. Proteomics 2005, 5, 4994-5001.
34. Adachi, J.; Kumar, C.; Zhang, Y.; Olsen, J. V.; Mann, M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
35. Bottini, P. V.; Ribeiro Alves, M. A.; Garlipp, C. R. Electrophoretic pattern of concentrated urine: comparison between 24-hour collection and random samples. Am. J. Kidney Dis. 2002, 39, E2.
36. Hoorn, E. J.; Pisitkun, T.; Zietse, R.; Gross, P.; Frokiaer, J.; Wang, N. S.; Gonzales, P. A.; Star, R. A.; Knepper, M. A. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton.) 2005, 10, 283-290.
37. Zhou, H.; Yuen, P. S.; Pisitkun, T.; Gonzales, P. A.; Yasuda, H.; Dear, J. W.; Gross, P.; Knepper, M. A.; Star, R. A. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006, 69, 1471-1476.
38. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S.; Jacks, K.; Smith, C.; Kireeva, I.; Zhang, R.; Takahashi, M.; Stanton, E.; Jackowski, G. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2003, 2, 361-372.
39. Rai, A. J.; Gelfand, C. A.; Haywood, B. C.; Warunek, D. J.; Yi, J.; Schuchard, M. D.; Mehigh, R. J.; Cockrill, S. L.; Scott, G. B.; Tammen, H.; Schulz-Knappe, P.; Speicher, D. W.; Vitzthum, F.; Haab, B. B.; Siest, G.; Chan, D. W. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5, 3262-3277.
40. Powell, T.; Taylor, T. P.; Janech, M. G.; Arthur, J. M. Change in the apparent proteome with repeated freeze-thaw cycles. J. Am. Soc. Nephrol. 2006, 17(suppl), 436A.
41. Weissinger, E. M.; Wittke, S.; Kaiser, T.; Haller, H.; Bartel, S.; Krebs, R.; Golovko, I.; Rupprecht, H. D.; Haubitz, M.; Hecker, H.; Mischak, H.; Fliser, D. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004, 65, 2426-2434.
42. Thongboonkerd, V.; Klein, E.; Klein, J. B. Sample preparation for 2-D proteomic analysis. Contrib. Nephrol. 2004, 141, 11-24.
43. Candiano, G.; Musante, L.; Bruschi, M.; Petretto, A.; Santucci, L.; Del, Boccio, P.; Pavone, B.; Perfumo, F.; Urbani, A.; Scolari, F.; Ghiggeri, G. M. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol. 2006, 17, 3139-3148.
44. Musante, L.; Candiano, G.; Petretto, A.; Bruschi, M.; Dimasi, N.; Caridi, G.; Pavone, B.; Del Boccio, P.; Galliano, M.; Urbani, A.; Scolari, F.; Vincenti, F.; Ghiggeri, G. M. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol. 2007, 18, 799-810.
45. Olivieri, O.; Castagna, A.; Guarini, P.; Chiecchi, L.; Sabaini, G.; Pizzolo, F.; Corrocher, R.; Righetti, P. G. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans. Hypertension 2005, 46, 683-688.
46. Decramer, S.; Wittke, S.; Mischak, H.; Zurbig, P.; Walden, M.; Bouissou, F.; Bascands, J. L.; Schanstra, J. P. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 2006, 12, 398-400.
47. Theodorescu, D.; Wittke, S.; Ross, M. M.; Walden, M.; Conaway, M.; Just, I.; Mischak, H.; Frierson, H. F. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 2006, 7, 230-240.
48. Hortin, G. L.; Sviridov, D. Diagnostic potential for urinary proteomics. Pharmacogenomics. 2007, 8, 237-255.